| Eva F Kubiczek Love, MD | |
|
9000 Franklin Square Dr, Baltimore, MD 21237-3901 | |
| (443) 777-7000 | |
| Not Available |
| Full Name | Eva F Kubiczek Love |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 9000 Franklin Square Dr, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043289978 | NPI | - | NPPES |
| 75859901 | Other | MD | BLUE SHIELD |
| 000631900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D0060324 (Maryland) | Primary |
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it will be offering its current inventory of monitors at or below cost to patients through its retail networks as it makes preparations for its next generation of cardiac monitors.
A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eva F Kubiczek Love, MD 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 | Eva F Kubiczek Love, MD 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 |
News Archive
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it will be offering its current inventory of monitors at or below cost to patients through its retail networks as it makes preparations for its next generation of cardiac monitors.
A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity.
› Verified 6 days ago
Hilary Tamara Wolf, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-7373 Fax: 410-328-7305 | |
Dr. Carmel Bogle, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 443-287-0526 Fax: 410-955-0897 | |
Anna Eunjoo Choe, Pediatrics Medicare: Medicare Enrolled Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205 Phone: 410-955-3362 Fax: 410-614-1582 | |
Dr. Melissa Lauren Shapiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215 Phone: 410-601-8663 | |
Dr. Alexander James Jaksic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 781-223-0948 | |
Adam J Spanier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Armory Pl, Baltimore, MD 21201 Phone: 410-225-8780 Fax: 410-225-8766 | |
Milagritos D Tapia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6749 Fax: 410-328-6136 |